{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:45:42Z","timestamp":1793997942312,"version":"4.8.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T00:00:00Z","timestamp":1737849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T00:00:00Z","timestamp":1737849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272140"],"award-info":[{"award-number":["82272140"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["ZXL2023212"],"award-info":[{"award-number":["ZXL2023212"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["ZXT2022007"],"award-info":[{"award-number":["ZXT2022007"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016086","name":"Key Laboratory in Science and Technology Development Project of Suzhou","doi-asserted-by":"publisher","award":["SZS2023006"],"award-info":[{"award-number":["SZS2023006"]}],"id":[{"id":"10.13039\/100016086","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04139-2","type":"journal-article","created":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T12:56:44Z","timestamp":1737896204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Advances in liver organoids: replicating hepatic complexity for toxicity assessment and disease modeling"],"prefix":"10.1186","volume":"16","author":[{"given":"Weidong","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanghua","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhou","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjun","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4419-9598","authenticated-orcid":false,"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,26]]},"reference":[{"issue":"1","key":"4139_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151\u201371.","journal-title":"J Hepatol"},{"issue":"6","key":"4139_CR2","doi-asserted-by":"publisher","first-page":"755","DOI":"10.4254\/wjh.v15.i6.755","volume":"15","author":"CY Zhang","year":"2023","unstructured":"Zhang CY, Liu S, Yang M. Treatment of liver fibrosis: past, current, and future. World J Hepatol. 2023;15(6):755\u201374.","journal-title":"World J Hepatol"},{"issue":"3","key":"4139_CR3","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jcmgh.2022.11.008","volume":"15","author":"S Kaur","year":"2023","unstructured":"Kaur S, Kidambi S, Ortega-Ribera M, Thuy LTT, Nieto N, Cogger VC, et al. Vitro models for the study of Liver Biology and diseases: advances and limitations. Cell Mol Gastroenterol Hepatol. 2023;15(3):559\u201371.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"4139_CR4","doi-asserted-by":"crossref","unstructured":"Hartung T. The (misleading) role of animal models in drug development. Front Drug Discovery. 2024;4.","DOI":"10.3389\/fddsv.2024.1355044"},{"key":"4139_CR5","doi-asserted-by":"crossref","unstructured":"Kammerer S. Three-Dimensional Liver Culture systems to maintain primary hepatic properties for Toxicological Analysis in Vitro. Int J Mol Sci. 2021;22(19).","DOI":"10.3390\/ijms221910214"},{"issue":"4","key":"4139_CR6","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s43441-023-00509-1","volume":"57","author":"E Kim","year":"2023","unstructured":"Kim E, Yang J, Park S, Shin K. Factors affecting success of New Drug Clinical trials. Therapeutic Innov Regul Sci. 2023;57(4):737\u201350.","journal-title":"Therapeutic Innov Regul Sci"},{"key":"4139_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-1-61779-367-7_8","volume-title":"Human cell culture protocols","author":"D Knobeloch","year":"2012","unstructured":"Knobeloch D, Ehnert S, Schyschka L, B\u00fcchler P, Schoenberg M, Kleeff J, et al. Human hepatocytes: isolation, culture, and Quality procedures. In: Mitry RR, Hughes RD, editors. Human cell culture protocols. Totowa, NJ: Humana; 2012. pp. 99\u2013120."},{"issue":"46","key":"4139_CR8","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.3748\/wjg.v12.i46.7413","volume":"12","author":"G Kolios","year":"2006","unstructured":"Kolios G, Valatas V, Kouroumalis E. Role of Kupffer cells in the pathogenesis of liver disease. World J Gastroenterol. 2006;12(46):7413\u201320.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4139_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0925-4773(02)00338-6","volume":"120","author":"N Fausto","year":"2003","unstructured":"Fausto N, Campbell JS. The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev. 2003;120(1):117\u201330.","journal-title":"Mech Dev"},{"issue":"10","key":"4139_CR10","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1091\/mbc.E19-03-0135","volume":"30","author":"R Lehmann","year":"2019","unstructured":"Lehmann R, Lee CM, Shugart EC, Benedetti M, Charo RA, Gartner Z, et al. Human organoids: a new dimension in cell biology. Mol Biol Cell. 2019;30(10):1129\u201337.","journal-title":"Mol Biol Cell"},{"issue":"3","key":"4139_CR11","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/ncb3312","volume":"18","author":"A Fatehullah","year":"2016","unstructured":"Fatehullah A, Tan SH, Barker N. Organoids as an in vitro model of human development and disease. Nat Cell Biol. 2016;18(3):246\u201354.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"4139_CR12","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.stemcr.2019.08.007","volume":"13","author":"S Akbari","year":"2019","unstructured":"Akbari S, Sevin\u00e7 GG, Ersoy N, Basak O, Kaplan K, Sevin\u00e7 K, et al. Robust, long-term culture of endoderm-derived hepatic organoids for Disease modeling. Stem cell Rep. 2019;13(4):627\u201341.","journal-title":"Stem cell Rep"},{"issue":"1","key":"4139_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/hep.32583","volume":"77","author":"N Jalan-Sakrikar","year":"2023","unstructured":"Jalan-Sakrikar N, Brevini T, Huebert RC, Sampaziotis F. Organoids and regenerative hepatology. Hepatology (Baltimore MD). 2023;77(1):305\u201322.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"5","key":"4139_CR14","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861\u201372.","journal-title":"Cell"},{"issue":"4","key":"4139_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.5966\/sctm.2013-0138","volume":"3","author":"C Borestr\u00f6m","year":"2014","unstructured":"Borestr\u00f6m C, Simonsson S, Enochson L, Bigdeli N, Brantsing C, Ellerstr\u00f6m C, et al. Footprint-Free Human Induced Pluripotent stem cells from articular cartilage with redifferentiation capacity: a first step toward a clinical-Grade Cell source. Stem Cells Translational Med. 2014;3(4):433\u201347.","journal-title":"Stem Cells Translational Med"},{"issue":"5","key":"4139_CR16","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","volume":"7","author":"L Warren","year":"2010","unstructured":"Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 2010;7(5):618\u201330.","journal-title":"Cell Stem Cell"},{"key":"4139_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.scr.2018.02.011","volume":"28","author":"A Artero Castro","year":"2018","unstructured":"Artero Castro A, Le\u00f3n M, Del Buey Furi\u00f3 V, Erceg S, Lukovic D. Generation of a human iPSC line by mRNA reprogramming. Stem cell Res. 2018;28:157\u201360.","journal-title":"Stem cell Res"},{"issue":"1","key":"4139_CR18","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41467-018-03190-3","volume":"9","author":"I Kogut","year":"2018","unstructured":"Kogut I, McCarthy SM, Pavlova M, Astling DP, Chen X, Jakimenko A, et al. High-efficiency RNA-based reprogramming of human primary fibroblasts. Nat Commun. 2018;9(1):745.","journal-title":"Nat Commun"},{"issue":"7827","key":"4139_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41586-020-2734-6","volume":"586","author":"X Liu","year":"2020","unstructured":"Liu X, Ouyang JF, Rossello FJ, Tan JP, Davidson KC, Valdes DS, et al. Reprogramming roadmap reveals route to human induced trophoblast stem cells. Nature. 2020;586(7827):101\u20137.","journal-title":"Nature"},{"issue":"7909","key":"4139_CR20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41586-022-04593-5","volume":"605","author":"J Guan","year":"2022","unstructured":"Guan J, Wang G, Wang J, Zhang Z, Fu Y, Cheng L, et al. Chemical reprogramming of human somatic cells to pluripotent stem cells. Nature. 2022;605(7909):325\u201331.","journal-title":"Nature"},{"issue":"6","key":"4139_CR21","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.stem.2018.10.018","volume":"23","author":"K Zhang","year":"2018","unstructured":"Zhang K, Zhang L, Liu W, Ma X, Cen J, Sun Z, et al. Expansion of primary human hepatocytes with efficient liver repopulation capacity. Cell Stem Cell. 2018;23(6):806\u2013e194.","journal-title":"Cell Stem Cell"},{"key":"4139_CR22","doi-asserted-by":"publisher","first-page":"8910821","DOI":"10.1155\/2017\/8910821","volume":"2017","author":"IV Kholodenko","year":"2017","unstructured":"Kholodenko IV, Yarygin KN. Cellular mechanisms of Liver Regeneration and Cell-based therapies of Liver diseases. Biomed Res Int. 2017;2017:8910821.","journal-title":"Biomed Res Int"},{"issue":"1","key":"4139_CR23","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s13287-021-02421-7","volume":"12","author":"C Shao","year":"2021","unstructured":"Shao C, Yang X, Jing Y, Hou X, Huang Y, Zong C, et al. The stemness of hepatocytes is maintained by high levels of lipopolysaccharide via YAP1 activation. Stem Cell Res Ther. 2021;12(1):342.","journal-title":"Stem Cell Res Ther"},{"issue":"7436","key":"4139_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature11826","volume":"494","author":"M Huch","year":"2013","unstructured":"Huch M, Dorrell C, Boj SF, van Es JH, Li VS, van de Wetering M, et al. In vitro expansion of single Lgr5\u2009+\u2009liver stem cells induced by wnt-driven regeneration. Nature. 2013;494(7436):247\u201350.","journal-title":"Nature"},{"issue":"3","key":"4139_CR25","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.stem.2014.01.003","volume":"14","author":"P Huang","year":"2014","unstructured":"Huang P, Zhang L, Gao Y, He Z, Yao D, Wu Z, et al. Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. Cell Stem Cell. 2014;14(3):370\u201384.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"4139_CR26","doi-asserted-by":"publisher","first-page":"e100134","DOI":"10.1371\/journal.pone.0100134","volume":"9","author":"KP Simeonov","year":"2014","unstructured":"Simeonov KP, Uppal H. Direct reprogramming of human fibroblasts to hepatocyte-like cells by synthetic modified mRNAs. PLoS ONE. 2014;9(6):e100134.","journal-title":"PLoS ONE"},{"issue":"3","key":"4139_CR27","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.stem.2013.06.017","volume":"13","author":"B Yu","year":"2013","unstructured":"Yu B, He ZY, You P, Han QW, Xiang D, Chen F, et al. Reprogramming fibroblasts into bipotential hepatic stem cells by defined factors. Cell Stem Cell. 2013;13(3):328\u201340.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"4139_CR28","doi-asserted-by":"publisher","first-page":"5292","DOI":"10.1038\/s41467-020-19041-z","volume":"11","author":"H Inada","year":"2020","unstructured":"Inada H, Udono M, Matsuda-Ito K, Horisawa K, Ohkawa Y, Miura S, et al. Direct reprogramming of human umbilical vein- and peripheral blood-derived endothelial cells into hepatic progenitor cells. Nat Commun. 2020;11(1):5292.","journal-title":"Nat Commun"},{"issue":"7459","key":"4139_CR29","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature12271","volume":"499","author":"T Takebe","year":"2013","unstructured":"Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T, et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature. 2013;499(7459):481\u20134.","journal-title":"Nature"},{"issue":"6","key":"4139_CR30","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.cell.2018.11.013","volume":"175","author":"H Hu","year":"2018","unstructured":"Hu H, Gehart H, Artegiani B, L\u00d6pez-Iglesias C, Dekkers F, Basak O, et al. Long-term expansion of functional mouse and human hepatocytes as 3D organoids. Cell. 2018;175(6):1591\u2013e60619.","journal-title":"Cell"},{"issue":"5","key":"4139_CR31","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.stem.2021.04.005","volume":"28","author":"A Marsee","year":"2021","unstructured":"Marsee A, Roos FJM, Verstegen MMA, Gehart H, de Koning E, Lemaigre F, et al. Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids. Cell Stem Cell. 2021;28(5):816\u201332.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"4139_CR32","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.jhep.2021.05.041","volume":"75","author":"M Bou Saleh","year":"2021","unstructured":"Bou Saleh M, Louvet A, Ntandja-Wandji LC, Boleslawski E, Gnemmi V, Lassailly G, et al. Loss of hepatocyte identity following aberrant YAP activation: a key mechanism in alcoholic hepatitis. J Hepatol. 2021;75(4):912\u201323.","journal-title":"J Hepatol"},{"issue":"1","key":"4139_CR33","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/s41467-017-01341-6","volume":"8","author":"Y Lin","year":"2017","unstructured":"Lin Y, Fang ZP, Liu HJ, Wang LJ, Cheng Z, Tang N, et al. HGF\/R-spondin1 rescues liver dysfunction through the induction of Lgr5(+) liver stem cells. Nat Commun. 2017;8(1):1175.","journal-title":"Nat Commun"},{"issue":"5","key":"4139_CR34","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1002\/hep.21582","volume":"45","author":"J Cai","year":"2007","unstructured":"Cai J, Zhao Y, Liu Y, Ye F, Song Z, Qin H, et al. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology (Baltimore MD). 2007;45(5):1229\u201339.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"2","key":"4139_CR35","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/hep.27165","volume":"60","author":"N Dianat","year":"2014","unstructured":"Dianat N, Dubois-Pot-Schneider H, Steichen C, Desterke C, Leclerc P, Raveux A, et al. Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells. Hepatology (Baltimore MD). 2014;60(2):700\u201314.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"10","key":"4139_CR36","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1007\/s00204-018-2280-2","volume":"92","author":"H Rashidi","year":"2018","unstructured":"Rashidi H, Luu NT, Alwahsh SM, Ginai M, Alhaque S, Dong H, et al. 3D human liver tissue from pluripotent stem cells displays stable phenotype in vitro and supports compromised liver function in vivo. Arch Toxicol. 2018;92(10):3117\u201329.","journal-title":"Arch Toxicol"},{"issue":"4","key":"4139_CR37","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/nprot.2017.011","volume":"12","author":"F Sampaziotis","year":"2017","unstructured":"Sampaziotis F, de Brito MC, Geti I, Bertero A, Hannan NR, Vallier L. Directed differentiation of human induced pluripotent stem cells into functional cholangiocyte-like cells. Nat Protoc. 2017;12(4):814\u201327.","journal-title":"Nat Protoc"},{"issue":"12","key":"4139_CR38","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/s41422-019-0242-8","volume":"29","author":"S Wang","year":"2019","unstructured":"Wang S, Wang X, Tan Z, Su Y, Liu J, Chang M, et al. Human ESC-derived expandable hepatic organoids enable therapeutic liver repopulation and pathophysiological modeling of alcoholic liver injury. Cell Res. 2019;29(12):1009\u201326.","journal-title":"Cell Res"},{"issue":"8","key":"4139_CR39","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/nbt.3294","volume":"33","author":"M Ogawa","year":"2015","unstructured":"Ogawa M, Ogawa S, Bear CE, Ahmadi S, Chin S, Li B, et al. Directed differentiation of cholangiocytes from human pluripotent stem cells. Nat Biotechnol. 2015;33(8):853\u201361.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"4139_CR40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1124\/dmd.105.006759","volume":"34","author":"C Aninat","year":"2006","unstructured":"Aninat C, Piton A, Glaise D, Le Charpentier T, Langou\u00ebt S, Morel F, et al. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells. Drug Metab Dispos. 2006;34(1):75\u201383.","journal-title":"Drug Metab Dispos"},{"key":"4139_CR41","doi-asserted-by":"crossref","unstructured":"Guan Y, Xu D, Garfin PM, Ehmer U, Hurwitz M, Enns G et al. Human hepatic organoids for the analysis of human genetic diseases. JCI Insight. 2017;2(17).","DOI":"10.1172\/jci.insight.94954"},{"issue":"6","key":"4139_CR42","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.jhep.2018.12.028","volume":"70","author":"F Wu","year":"2019","unstructured":"Wu F, Wu D, Ren Y, Huang Y, Feng B, Zhao N, et al. Generation of hepatobiliary organoids from human induced pluripotent stem cells. J Hepatol. 2019;70(6):1145\u201358.","journal-title":"J Hepatol"},{"issue":"4","key":"4139_CR43","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1053\/j.gastro.2020.06.010","volume":"159","author":"MNB Ramli","year":"2020","unstructured":"Ramli MNB, Lim YS, Koe CT, Demircioglu D, Tng W, Gonzales KAU, et al. Human pluripotent stem cell-derived Organoids as models of Liver Disease. Gastroenterology. 2020;159(4):1471\u2013e8612.","journal-title":"Gastroenterology"},{"issue":"7776","key":"4139_CR44","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41586-019-1598-0","volume":"574","author":"H Koike","year":"2019","unstructured":"Koike H, Iwasawa K, Ouchi R, Maezawa M, Giesbrecht K, Saiki N, et al. Modelling human hepato-biliary-pancreatic organogenesis from the foregut-midgut boundary. Nature. 2019;574(7776):112\u20136.","journal-title":"Nature"},{"issue":"5","key":"4139_CR45","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.stem.2020.02.002","volume":"26","author":"X Qian","year":"2020","unstructured":"Qian X, Su Y, Adam CD, Deutschmann AU, Pather SR, Goldberg EM, et al. Sliced human cortical organoids for modeling distinct cortical layer formation. Cell Stem Cell. 2020;26(5):766\u2013e819.","journal-title":"Cell Stem Cell"},{"issue":"7740","key":"4139_CR46","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41586-018-0858-8","volume":"565","author":"RA Wimmer","year":"2019","unstructured":"Wimmer RA, Leopoldi A, Aichinger M, Wick N, Hantusch B, Novatchkova M, et al. Human blood vessel organoids as a model of diabetic vasculopathy. Nature. 2019;565(7740):505\u201310.","journal-title":"Nature"},{"issue":"1","key":"4139_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cels.2020.11.002","volume":"12","author":"JJ Velazquez","year":"2021","unstructured":"Velazquez JJ, LeGraw R, Moghadam F, Tan Y, Kilbourne J, Maggiore JC, et al. Gene Regulatory Network Analysis and Engineering Directs Development and Vascularization of Multilineage Human Liver Organoids. Cell Syst. 2021;12(1):41\u2013e5511.","journal-title":"Cell Syst"},{"issue":"2","key":"4139_CR48","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cmet.2019.05.007","volume":"30","author":"R Ouchi","year":"2019","unstructured":"Ouchi R, Togo S, Kimura M, Shinozawa T, Koido M, Koike H, et al. Modeling steatohepatitis in humans with pluripotent stem cell-derived Organoids. Cell Metabol. 2019;30(2):374\u2013.\u2013\u200984.e6.","journal-title":"Cell Metabol"},{"issue":"3","key":"4139_CR49","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1053\/j.gastro.2020.10.002","volume":"160","author":"T Shinozawa","year":"2021","unstructured":"Shinozawa T, Kimura M, Cai Y, Saiki N, Yoneyama Y, Ouchi R, et al. High-Fidelity Drug-Induced Liver Injury screen using human pluripotent stem cell-derived Organoids. Gastroenterology. 2021;160(3):831\u2013e4610.","journal-title":"Gastroenterology"},{"issue":"9","key":"4139_CR50","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1038\/s12276-023-01074-1","volume":"55","author":"SP Harrison","year":"2023","unstructured":"Harrison SP, Siller R, Tanaka Y, Chollet ME, de la Morena-Barrio ME, Xiang Y, et al. Scalable production of tissue-like vascularized liver organoids from human PSCs. Exp Mol Med. 2023;55(9):2005\u201324.","journal-title":"Exp Mol Med"},{"key":"4139_CR51","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fbioe.2020.00325","volume":"8","author":"RB Shinde","year":"2020","unstructured":"Shinde RB, Veerapandian M, Kaushik A, Manickam P. State-of-art Bio-assay systems and Electrochemical approaches for Nanotoxicity Assessment. Front Bioeng Biotechnol. 2020;8:325.","journal-title":"Front Bioeng Biotechnol"},{"key":"4139_CR52","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.actbio.2020.02.015","volume":"106","author":"SAP Rajan","year":"2020","unstructured":"Rajan SAP, Aleman J, Wan M, Pourhabibi Zarandi N, Nzou G, Murphy S, et al. Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform. Acta Biomater. 2020;106:124\u201335.","journal-title":"Acta Biomater"},{"issue":"8","key":"4139_CR53","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1111\/liv.14942","volume":"41","author":"MA Polidoro","year":"2021","unstructured":"Polidoro MA, Ferrari E, Marzorati S, Lleo A, Rasponi M. Experimental liver models: from cell culture techniques to microfluidic organs-on-chip. Liver Int. 2021;41(8):1744\u201361.","journal-title":"Liver Int"},{"key":"4139_CR54","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3389\/fphar.2017.00527","volume":"8","author":"Z Liu","year":"2017","unstructured":"Liu Z, Yang Y, Sheng L, Li Y. Interspecies Variation of in Vitro Stability and Metabolic Diversity of YZG-331, a promising sedative-hypnotic compound. Front Pharmacol. 2017;8:527.","journal-title":"Front Pharmacol"},{"issue":"6","key":"4139_CR55","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/smll.201401915","volume":"11","author":"SL Chia","year":"2015","unstructured":"Chia SL, Tay CY, Setyawati MI, Leong DT. Biomimicry 3D gastrointestinal spheroid platform for the assessment of toxicity and inflammatory effects of zinc oxide nanoparticles. Small. 2015;11(6):702\u201312.","journal-title":"Small"},{"issue":"4","key":"4139_CR56","first-page":"910","volume":"14","author":"M Kapa\u0142czy\u0144ska","year":"2018","unstructured":"Kapa\u0142czy\u0144ska M, Kolenda T, Przyby\u0142a W, Zaj\u0105czkowska M, Teresiak A, Filas V, et al. 2D and 3D cell cultures - a comparison of different types of cancer cell cultures. Archives Med Science: AMS. 2018;14(4):910\u20139.","journal-title":"Archives Med Science: AMS"},{"issue":"14","key":"4139_CR57","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMc1911063","volume":"381","author":"S Rathi","year":"2019","unstructured":"Rathi S, Kumar P. Drug-Induced Liver Injury - types and phenotypes. N Engl J Med. 2019;381(14):1395.","journal-title":"N Engl J Med"},{"issue":"6","key":"4139_CR58","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrd4309","volume":"13","author":"D Cook","year":"2014","unstructured":"Cook D, Brown D, Alexander R, March R, Morgan P, Satterthwaite G, et al. Lessons learned from the fate of AstraZeneca\u2019s drug pipeline: a five-dimensional framework. Nat Rev Drug Discovery. 2014;13(6):419\u201331.","journal-title":"Nat Rev Drug Discovery"},{"issue":"6","key":"4139_CR59","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1002\/hep.23937","volume":"52","author":"A Reuben","year":"2010","unstructured":"Reuben A, Koch DG, Lee WM. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology (Baltimore MD). 2010;52(6):2065\u201376.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"1","key":"4139_CR60","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/toxsci\/kfs083","volume":"127","author":"L Tolosa","year":"2012","unstructured":"Tolosa L, Pinto S, Donato MT, Lahoz A, Castell JV, O\u2019Connor JE, et al. Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs. Toxicol Sci. 2012;127(1):187\u201398.","journal-title":"Toxicol Sci"},{"issue":"1","key":"4139_CR61","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/toxsci\/kfv117","volume":"147","author":"J Lu","year":"2015","unstructured":"Lu J, Einhorn S, Venkatarangan L, Miller M, Mann DA, Watkins PB, et al. Morphological and functional characterization and Assessment of iPSC-Derived hepatocytes for in Vitro Toxicity Testing. Toxicol Sci. 2015;147(1):39\u201354.","journal-title":"Toxicol Sci"},{"issue":"1","key":"4139_CR62","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.vascn.2010.04.013","volume":"63","author":"M L\u00fcbberstedt","year":"2011","unstructured":"L\u00fcbberstedt M, M\u00fcller-Vieira U, Mayer M, Biemel KM, Kn\u00f6spel F, Knobeloch D, et al. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro. J Pharmacol Toxicol Methods. 2011;63(1):59\u201368.","journal-title":"J Pharmacol Toxicol Methods"},{"key":"4139_CR63","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.tiv.2016.02.019","volume":"33","author":"J Saito","year":"2016","unstructured":"Saito J, Okamura A, Takeuchi K, Hanioka K, Okada A, Ohata T. High content analysis assay for prediction of human hepatotoxicity in HepaRG and HepG2 cells. Toxicol Vitro. 2016;33:63\u201370.","journal-title":"Toxicol Vitro"},{"issue":"11","key":"4139_CR64","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1517\/17425255.2014.967680","volume":"10","author":"MJ G\u00f3mez-Lech\u00f3n","year":"2014","unstructured":"G\u00f3mez-Lech\u00f3n MJ, Tolosa L, Conde I, Donato MT. Competency of different cell models to predict human hepatotoxic drugs. Expert Opin Drug Metab Toxicol. 2014;10(11):1553\u201368.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"4139_CR65","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1124\/dmd.110.035873","volume":"39","author":"L Guo","year":"2011","unstructured":"Guo L, Dial S, Shi L, Branham W, Liu J, Fang JL, et al. Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes. Drug Metab Dispos. 2011;39(3):528\u201338.","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"4139_CR66","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s13287-020-01914-1","volume":"11","author":"X Gao","year":"2020","unstructured":"Gao X, Li R, Cahan P, Zhao Y, Yourick JJ, Sprando RL. Hepatocyte-like cells derived from human induced pluripotent stem cells using small molecules: implications of a transcriptomic study. Stem Cell Res Ther. 2020;11(1):393.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"4139_CR67","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s40139-017-0150-x","volume":"5","author":"R Siller","year":"2017","unstructured":"Siller R, Greenhough S, Mathapati S, Si-Tayeb K, Sullivan GJ. Future challenges in the generation of hepatocyte-like cells from human pluripotent stem cells. Curr Pathobiology Rep. 2017;5(3):301\u201314.","journal-title":"Curr Pathobiology Rep"},{"issue":"5","key":"4139_CR68","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.jhep.2019.06.030","volume":"71","author":"SJ Mun","year":"2019","unstructured":"Mun SJ, Ryu JS, Lee MO, Son YS, Oh SJ, Cho HS, et al. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids. J Hepatol. 2019;71(5):970\u201385.","journal-title":"J Hepatol"},{"key":"4139_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.11.026","volume":"78","author":"SB Leite","year":"2016","unstructured":"Leite SB, Roosens T, El Taghdouini A, Mannaerts I, Smout AJ, Najimi M, et al. Novel human hepatic organoid model enables testing of drug-induced liver fibrosis in vitro. Biomaterials. 2016;78:1\u201310.","journal-title":"Biomaterials"},{"issue":"20","key":"4139_CR70","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1089\/scd.2017.0023","volume":"26","author":"M Sgodda","year":"2017","unstructured":"Sgodda M, Dai Z, Zweigerdt R, Sharma AD, Ott M, Cantz T. A Scalable Approach for the generation of human pluripotent stem cell-derived hepatic organoids with sensitive hepatotoxicity features. Stem Cells Dev. 2017;26(20):1490\u2013504.","journal-title":"Stem Cells Dev"},{"key":"4139_CR71","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fpubh.2018.00103","volume":"6","author":"SD Forsythe","year":"2018","unstructured":"Forsythe SD, Devarasetty M, Shupe T, Bishop C, Atala A, Soker S, et al. Environmental toxin screening using human-derived 3D Bioengineered Liver and Cardiac Organoids. Front Public Health. 2018;6:103.","journal-title":"Front Public Health"},{"key":"4139_CR72","doi-asserted-by":"crossref","unstructured":"Lee JY, Han HJ, Lee SJ, Cho EH, Lee HB, Seok JH et al. Use of 3D human liver organoids to Predict Drug-Induced Phospholipidosis. Int J Mol Sci. 2020;21(8).","DOI":"10.3390\/ijms21082982"},{"issue":"3","key":"4139_CR73","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1021\/ar300031y","volume":"46","author":"M Zhu","year":"2013","unstructured":"Zhu M, Nie G, Meng H, Xia T, Nel A, Zhao Y. Physicochemical properties determine nanomaterial cellular uptake, transport, and fate. Acc Chem Res. 2013;46(3):622\u201331.","journal-title":"Acc Chem Res"},{"key":"4139_CR74","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3762\/bjnano.9.98","volume":"9","author":"J Jeevanandam","year":"2018","unstructured":"Jeevanandam J, Barhoum A, Chan YS, Dufresne A, Danquah MK. Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations. Beilstein J Nanotechnol. 2018;9:1050\u201374.","journal-title":"Beilstein J Nanotechnol"},{"issue":"1","key":"4139_CR75","doi-asserted-by":"publisher","first-page":"7295","DOI":"10.1038\/s41598-019-43870-8","volume":"9","author":"A Kermanizadeh","year":"2019","unstructured":"Kermanizadeh A, Brown DM, Moritz W, Stone V. The importance of inter-individual Kupffer cell variability in the governance of hepatic toxicity in a 3D primary human liver microtissue model. Sci Rep. 2019;9(1):7295.","journal-title":"Sci Rep"},{"issue":"4","key":"4139_CR76","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/10937404.2020.1751756","volume":"23","author":"A Kermanizadeh","year":"2020","unstructured":"Kermanizadeh A, Powell LG, Stone V. A review of hepatic nanotoxicology - summation of recent findings and considerations for the next generation of study designs. J Toxicol Environ Health Part B Crit Reviews. 2020;23(4):137\u201376.","journal-title":"J Toxicol Environ Health Part B Crit Reviews"},{"issue":"1","key":"4139_CR77","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12989-019-0326-0","volume":"16","author":"A Kermanizadeh","year":"2019","unstructured":"Kermanizadeh A, Berthing T, Guzniczak E, Wheeldon M, Whyte G, Vogel U, et al. Assessment of nanomaterial-induced hepatotoxicity using a 3D human primary multi-cellular microtissue exposed repeatedly over 21 days - the suitability of the in vitro system as an in vivo surrogate. Part Fibre Toxicol. 2019;16(1):42.","journal-title":"Part Fibre Toxicol"},{"issue":"8","key":"4139_CR78","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1038\/s12276-020-0483-0","volume":"52","author":"J So","year":"2020","unstructured":"So J, Kim A, Lee SH, Shin D. Liver progenitor cell-driven liver regeneration. Exp Mol Med. 2020;52(8):1230\u20138.","journal-title":"Exp Mol Med"},{"issue":"9","key":"4139_CR79","doi-asserted-by":"publisher","first-page":"100161","DOI":"10.1016\/j.xcrm.2020.100161","volume":"1","author":"S Jiang","year":"2020","unstructured":"Jiang S, Zhao H, Zhang W, Wang J, Liu Y, Cao Y, et al. An Automated Organoid platform with inter-organoid homogeneity and inter-patient heterogeneity. Cell Rep Med. 2020;1(9):100161.","journal-title":"Cell Rep Med"},{"issue":"3","key":"4139_CR80","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jcmgh.2017.11.012","volume":"5","author":"GH Underhill","year":"2018","unstructured":"Underhill GH, Khetani SR. Bioengineered liver models for drug testing and cell differentiation studies. Cell Mol Gastroenterol Hepatol. 2018;5(3):426\u2013e391.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"6","key":"4139_CR81","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s13770-020-00245-9","volume":"17","author":"SW Lee","year":"2020","unstructured":"Lee SW, Jung DJ, Jeong GS. Gaining New Biological and therapeutic applications into the liver with 3D in Vitro Liver models. Tissue Eng Regenerative Med. 2020;17(6):731\u201345.","journal-title":"Tissue Eng Regenerative Med"},{"issue":"17","key":"4139_CR82","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1039\/C4LC00531G","volume":"14","author":"SH Au","year":"2014","unstructured":"Au SH, Chamberlain MD, Mahesh S, Sefton MV, Wheeler AR. Hepatic organoids for microfluidic drug screening. Lab Chip. 2014;14(17):3290\u20139.","journal-title":"Lab Chip"},{"issue":"16","key":"4139_CR83","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1039\/C4LC00371C","volume":"14","author":"MB Esch","year":"2014","unstructured":"Esch MB, Mahler GJ, Stokol T, Shuler ML. Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injury. Lab Chip. 2014;14(16):3081\u201392.","journal-title":"Lab Chip"},{"issue":"16","key":"4139_CR84","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.2217\/nnm-2019-0086","volume":"14","author":"L Li","year":"2019","unstructured":"Li L, Gokduman K, Gokaltun A, Yarmush ML, Usta OB. A microfluidic 3D hepatocyte chip for hepatotoxicity testing of nanoparticles. Nanomed (London England). 2019;14(16):2209\u201326.","journal-title":"Nanomed (London England)"},{"key":"4139_CR85","doi-asserted-by":"crossref","unstructured":"Jin Y, Kim J, Lee JS, Min S, Kim S, Ahn DH et al. Vascularized liver organoids generated using Induced hepatic tissue and dynamic liver-specific Microenvironment as a drug testing platform. Adv Funct Mater. 2018;28(37).","DOI":"10.1002\/adfm.201801954"},{"key":"4139_CR86","doi-asserted-by":"crossref","unstructured":"Jang KJ, Otieno MA, Ronxhi J, Lim HK, Ewart L, Kodella KR et al. Reproducing human and cross-species drug toxicities using a liver-chip. Sci Transl Med. 2019;11(517).","DOI":"10.1126\/scitranslmed.aax5516"},{"issue":"45","key":"4139_CR87","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.3748\/wjg.v24.i45.5063","volume":"24","author":"A Lamas-Paz","year":"2018","unstructured":"Lamas-Paz A, Hao F, Nelson LJ, V\u00e1zquez MT, Canals S, Del G\u00f3mez M, et al. Alcoholic liver disease: utility of animal models. World J Gastroenterol. 2018;24(45):5063\u201375.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"4139_CR88","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","volume":"49","author":"E Cobbina","year":"2017","unstructured":"Cobbina E, Akhlaghi F. Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Drug Metab Rev. 2017;49(2):197\u2013211.","journal-title":"Drug Metab Rev"},{"issue":"11","key":"4139_CR89","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","volume":"2","author":"H Yki-J\u00e4rvinen","year":"2014","unstructured":"Yki-J\u00e4rvinen H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol. 2014;2(11):901\u201310.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"4139_CR90","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cld.2015.10.011","volume":"20","author":"DE Kleiner","year":"2016","unstructured":"Kleiner DE, Makhlouf HR. Histology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in adults and children. Clin Liver Dis. 2016;20(2):293\u2013312.","journal-title":"Clin Liver Dis"},{"issue":"2","key":"4139_CR91","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3748\/wjg.v25.i2.163","volume":"25","author":"N Tanaka","year":"2019","unstructured":"Tanaka N, Kimura T, Fujimori N, Nagaya T, Komatsu M, Tanaka E. Current status, problems, and perspectives of non-alcoholic fatty liver disease research. World J Gastroenterol. 2019;25(2):163\u201377.","journal-title":"World J Gastroenterol"},{"key":"4139_CR92","doi-asserted-by":"crossref","unstructured":"Pingitore P, Sasidharan K, Ekstrand M, Prill S, Lind\u00e9n D, Romeo S. Human multilineage 3D spheroids as a model of liver steatosis and fibrosis. Int J Mol Sci. 2019;20(7).","DOI":"10.3390\/ijms20071629"},{"issue":"11","key":"4139_CR93","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/s41587-023-01680-4","volume":"41","author":"D Hendriks","year":"2023","unstructured":"Hendriks D, Brouwers JF, Hamer K, Geurts MH, Luciana L, Massalini S, et al. Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis. Nat Biotechnol. 2023;41(11):1567\u201381.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"4139_CR94","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1055\/s-0036-1571295","volume":"36","author":"YJ Yoon","year":"2016","unstructured":"Yoon YJ, Friedman SL, Lee YA. Antifibrotic therapies: where are we now? Semin Liver Dis. 2016;36(1):87\u201398.","journal-title":"Semin Liver Dis"},{"key":"4139_CR95","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","volume":"6","author":"V Hernandez-Gea","year":"2011","unstructured":"Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011;6:425\u201356.","journal-title":"Annu Rev Pathol"},{"key":"4139_CR96","doi-asserted-by":"crossref","unstructured":"Pinzani M, Luong TV. Pathogenesis of biliary fibrosis. Biochimica et biophysica acta molecular basis of disease. 2018;1864(4 Pt B):1279\u201383.","DOI":"10.1016\/j.bbadis.2017.07.026"},{"key":"4139_CR97","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","volume":"65","author":"M Parola","year":"2019","unstructured":"Parola M, Pinzani M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019;65:37\u201355.","journal-title":"Mol Aspects Med"},{"key":"4139_CR98","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.addr.2017.05.018","volume":"121","author":"G Mazza","year":"2017","unstructured":"Mazza G, Al-Akkad W, Rombouts K. Engineering in vitro models of hepatofibrogenesis. Adv Drug Deliv Rev. 2017;121:147\u201357.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"4139_CR99","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/ncb3510","volume":"19","author":"YW Chen","year":"2017","unstructured":"Chen YW, Huang SX, de Carvalho A, Ho SH, Islam MN, Volpi S, et al. A three-dimensional model of human lung development and disease from pluripotent stem cells. Nat Cell Biol. 2017;19(5):542\u20139.","journal-title":"Nat Cell Biol"},{"key":"4139_CR100","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.biomaterials.2016.10.046","volume":"113","author":"Q Tan","year":"2017","unstructured":"Tan Q, Choi KM, Sicard D, Tschumperlin DJ. Human airway organoid engineering as a step toward lung regeneration and disease modeling. Biomaterials. 2017;113:118\u201332.","journal-title":"Biomaterials"},{"issue":"1","key":"4139_CR101","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1038\/s41598-017-02190-5","volume":"7","author":"S Hahn","year":"2017","unstructured":"Hahn S, Nam MO, Noh JH, Lee DH, Han HW, Kim DH, et al. Organoid-based epithelial to mesenchymal transition (OEMT) model: from an intestinal fibrosis perspective. Sci Rep. 2017;7(1):2435.","journal-title":"Sci Rep"},{"issue":"8","key":"4139_CR102","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1002\/bit.27379","volume":"117","author":"M Brovold","year":"2020","unstructured":"Brovold M, Keller D, Soker S. Differential fibrotic phenotypes of hepatic stellate cells within 3D liver organoids. Biotechnol Bioeng. 2020;117(8):2516\u201326.","journal-title":"Biotechnol Bioeng"},{"issue":"1","key":"4139_CR103","doi-asserted-by":"publisher","first-page":"6138","DOI":"10.1038\/s41467-021-26410-9","volume":"12","author":"Y Guan","year":"2021","unstructured":"Guan Y, Enejder A, Wang M, Fang Z, Cui L, Chen SY, et al. A human multi-lineage hepatic organoid model for liver fibrosis. Nat Commun. 2021;12(1):6138.","journal-title":"Nat Commun"},{"issue":"3","key":"4139_CR104","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/hep.29905","volume":"68","author":"JA Bezerra","year":"2018","unstructured":"Bezerra JA, Wells RG, Mack CL, Karpen SJ, Hoofnagle JH, Doo E, et al. Biliary atresia: clinical and Research challenges for the twenty-First Century. Hepatology (Baltimore MD). 2018;68(3):1163\u201373.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"10","key":"4139_CR105","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.jpedsurg.2015.03.001","volume":"50","author":"A Zani","year":"2015","unstructured":"Zani A, Quaglia A, Hadzi\u0107 N, Zuckerman M, Davenport M. Cytomegalovirus-associated biliary atresia: an aetiological and prognostic subgroup. J Pediatr Surg. 2015;50(10):1739\u201345.","journal-title":"J Pediatr Surg"},{"issue":"6","key":"4139_CR106","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.gastrohep.2018.01.014","volume":"41","author":"B Wahid","year":"2018","unstructured":"Wahid B, Ali A, Rafique S, Saleem K, Waqar M, Wasim M, et al. Role of altered immune cells in liver diseases: a review. Gastroenterol Hepatol. 2018;41(6):377\u201388.","journal-title":"Gastroenterol Hepatol"},{"issue":"12","key":"4139_CR107","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1007\/s00383-020-04765-2","volume":"36","author":"S Chusilp","year":"2020","unstructured":"Chusilp S, Lee C, Li B, Lee D, Yamoto M, Ganji N, et al. A novel model of injured liver ductal organoids to investigate cholangiocyte apoptosis with relevance to biliary atresia. Pediatr Surg Int. 2020;36(12):1471\u20139.","journal-title":"Pediatr Surg Int"},{"issue":"1","key":"4139_CR108","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1172\/JCI93562","volume":"128","author":"L Cordero-Espinoza","year":"2018","unstructured":"Cordero-Espinoza L, Huch M. The balancing act of the liver: tissue regeneration versus fibrosis. J Clin Investig. 2018;128(1):85\u201396.","journal-title":"J Clin Investig"},{"issue":"3","key":"4139_CR109","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nri3169","volume":"12","author":"U Protzer","year":"2012","unstructured":"Protzer U, Maini MK, Knolle PA. Living in the liver: hepatic infections. Nat Rev Immunol. 2012;12(3):201\u201313.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"4139_CR110","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.chom.2018.02.005","volume":"23","author":"Y Baktash","year":"2018","unstructured":"Baktash Y, Madhav A, Coller KE, Randall G. Single particle imaging of polarized Hepatoma Organoids upon Hepatitis C virus infection reveals an ordered and sequential entry process. Cell Host Microbe. 2018;23(3):382\u2013e945.","journal-title":"Cell Host Microbe"},{"issue":"10003","key":"4139_CR111","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/S0140-6736(15)61116-3","volume":"386","author":"JH MacLachlan","year":"2015","unstructured":"MacLachlan JH, Locarnini S, Cowie BC. Estimating the global prevalence of hepatitis B. Lancet (London England). 2015;386(10003):1515\u20137.","journal-title":"Lancet (London England)"},{"key":"4139_CR112","doi-asserted-by":"crossref","unstructured":"De Crignis E, Hossain T, Romal S, Carofiglio F, Moulos P, Khalid MM et al. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma. eLife. 2021;10.","DOI":"10.7554\/eLife.60747"},{"key":"4139_CR113","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.parkreldis.2019.02.016","volume":"59","author":"P Hedera","year":"2019","unstructured":"Hedera P. Wilson\u2019s disease: a master of disguise. Parkinsonism Relat Disord. 2019;59:140\u20135.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"4139_CR114","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1474-4422(14)70190-5","volume":"14","author":"O Bandmann","year":"2015","unstructured":"Bandmann O, Weiss KH, Kaler SG. Wilson\u2019s disease and other neurological copper disorders. Lancet Neurol. 2015;14(1):103\u201313.","journal-title":"Lancet Neurol"},{"issue":"5","key":"4139_CR115","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.stemcr.2015.09.002","volume":"5","author":"S Nantasanti","year":"2015","unstructured":"Nantasanti S, Spee B, Kruitwagen HS, Chen C, Geijsen N, Oosterhoff LA, et al. Disease modeling and Gene Therapy of Copper Storage Disease in Canine hepatic organoids. Stem cell Rep. 2015;5(5):895\u2013907.","journal-title":"Stem cell Rep"},{"issue":"1","key":"4139_CR116","doi-asserted-by":"publisher","first-page":"5352","DOI":"10.1038\/s41467-020-19136-7","volume":"11","author":"IF Schene","year":"2020","unstructured":"Schene IF, Joore IP, Oka R, Mokry M, van Vugt AHM, van Boxtel R, et al. Prime editing for functional repair in patient-derived disease models. Nat Commun. 2020;11(1):5352.","journal-title":"Nat Commun"},{"issue":"10","key":"4139_CR117","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.rmr.2014.03.015","volume":"31","author":"A Duvoix","year":"2014","unstructured":"Duvoix A, Roussel BD, Lomas DA. Molecular pathogenesis of alpha-1-antitrypsin deficiency. Rev Mal Respir. 2014;31(10):992\u20131002.","journal-title":"Rev Mal Respir"},{"key":"4139_CR118","doi-asserted-by":"publisher","first-page":"16051","DOI":"10.1038\/nrdp.2016.51","volume":"2","author":"CM Greene","year":"2016","unstructured":"Greene CM, Marciniak SJ, Teckman J, Ferrarotti I, Brantly ML, Lomas DA, et al. \u03b11-Antitrypsin deficiency. Nat Reviews Disease Primers. 2016;2:16051.","journal-title":"Nat Reviews Disease Primers"},{"issue":"6","key":"4139_CR119","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1172\/JCI112524","volume":"77","author":"JF Mornex","year":"1986","unstructured":"Mornex JF, Chytil-Weir A, Martinet Y, Courtney M, LeCocq JP, Crystal RG. Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals. J Clin Investig. 1986;77(6):1952\u201361.","journal-title":"J Clin Investig"},{"issue":"1","key":"4139_CR120","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12072-019-10007-y","volume":"14","author":"G G\u00f3mez-Mariano","year":"2020","unstructured":"G\u00f3mez-Mariano G, Matamala N, Mart\u00ednez S, Justo I, Marcacuzco A, Jimenez C, et al. Liver organoids reproduce alpha-1 antitrypsin deficiency-related liver disease. Hep Intl. 2020;14(1):127\u201337.","journal-title":"Hep Intl"},{"issue":"1\u20132","key":"4139_CR121","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","volume":"160","author":"M Huch","year":"2015","unstructured":"Huch M, Gehart H, van Boxtel R, Hamer K, Blokzijl F, Verstegen MM, et al. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell. 2015;160(1\u20132):299\u2013312.","journal-title":"Cell"},{"issue":"7","key":"4139_CR122","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s12098-019-02905-8","volume":"86","author":"A Janwadkar","year":"2019","unstructured":"Janwadkar A, Shirole N, Nagral A, Bakshi R, Vasanth S, Bagde A, et al. Citrullinemia type 1: behavioral improvement with late liver transplantation. Indian J Pediatr. 2019;86(7):639\u201341.","journal-title":"Indian J Pediatr"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04139-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04139-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04139-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T13:50:54Z","timestamp":1737899454000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04139-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,26]]},"references-count":122,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4139"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04139-2","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,26]]},"assertion":[{"value":"4 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors give their consent for publication in Stem Cell Research & Therapy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have used artificial intelligence to polish the grammar of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI usage"}},{"value":"The authors declare that they have no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"27"}}